Dr. Valerie Fritz

List of publications:

BibTeX-Download

Lehrstuhl für Biochemie und Molekulare Medizin

Publications

(7)

The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche (2025) Wormser L, Fritz V, Kappelmann-Fenzl M, Rachinger N, Escudé P, Enderle K, Kaufmann M, et al. Journal article Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11 (2021) Gaza A, Fritz V, Malek L, Wormser L, Treiber N, Danner J, Kremer AE, et al. Journal article Combined de‐repression of chemoresistance associated mitogen‐activated protein kinase 14 and activating transcription factor 2 by loss of microrna‐622 in hepatocellular carcinoma (2021) Fritz V, Malek L, Gaza A, Wormser L, Appel M, Kremer A, Thasler WE, et al. Journal article Molecular cross-talk between Y5-receptor and neuropeptide Y drives liver cancer (2020) Dietrich P, Wormser L, Fritz V, Seitz T, de Maria M, Schambony A, Kremer A, et al. Journal article Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p (2019) Goeppert B, Truckenmueller F, Ori A, Fritz V, Albrecht T, Fraas A, Scherer D, et al. Journal article Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma (2019) Dietrich P, Gaza A, Wormser L, Fritz V, Hellerbrand C, Boßerhoff AK Journal article Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance (2017) Dietrich P, Koch A, Fritz V, Hartmann A, Boßerhoff AK, Hellerbrand C Journal article